RT Journal Article
SR Electronic
T1 Hasty Reduction of COVID-19 Lockdown Measures Leads to the Second Wave of Infection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.23.20111526
DO 10.1101/2020.05.23.20111526
A1 Hazem, Yara
A1 Natarajan, Suchitra
A1 Berikaa, Essam R.
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.23.20111526.abstract
AB The outbreak of COVID-19 has an undeniable global impact, both socially and economically. March 11th, 2020, COVID-19 was declared as a pandemic worldwide. Many governments, worldwide, have imposed strict lockdown measures to minimize the spread of COVID-19. However, these measures cannot last forever; therefore, many countries are already considering relaxing the lockdown measures. This study, quantitatively, investigated the impact of this relaxation in the United States, Germany, the United Kingdom, Italy, Spain, and Canada. A modified version of the SIR model is used to model the reduction in lockdown based on the already available data. The results showed an inevitable second wave of COVID-19 infection following loosening the current measures. The study tries to reveal the predicted number of infected cases for different reopening dates. Additionally, the predicted number of infected cases for different reopening dates is reported.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is based on a computational approach and does not require any source of funding and aims to benefit the public.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study does not include any human trails.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe study is based on the Modelling of the COVID-19 Pandemic, the data are already available from different sources as WHO. https://github.com/CSSEGISandData/COVID-19